Table 3.

Development of point-of-care (POC) and a revolutionary nearly 100% sensitive and specific test for acquisition of Toxoplasma gondii

Concept	References
Development of test	[80••]
Application of test to serum	[43••]
Applicability to infections in the United States	[43••]
Meeting WHO ASSURED criteria with POC test	[44••]
Implementation and building a global initiative	[33••, 39••, 48••, 52, 55••, 58••, 60••, 61, 66••, 67••, 81••]
Scaling in Morocco, Panamá, Colombia, Brazil, Argentina, Europe, and the U.S.	[57•], In Progress
Multiplexing: Nano-Gold test	[82]